- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
O
OMER
Omeros
10.24
-0.09-0.87%After Hours: 10.46 +0.22 +2.18%17:05 07/08 EDT
OPEN/PREV CLOSE10.28/10.33
TODAY RANGE10.24-10.69
VOL1.50M
MARKET CAP741.12M
52 WEEK RANGE3.000-17.65
AVG VOL (3M)1.77M
% TURNOVER2.07%
TURNOVER--
P/E (TTM)10.88
% RANGE4.31%
EPS(TTM)0.9410
P/E(FORWARD)68.27
P/B-11.6403
BVPS-0.8797
DIVIDEND--
P/S3.966
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP714.76M
SHARES OUTSTANDING72.38M
NEXT EARNINGS08/12-08/17
FREE FLOAT69.80M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Omeros: Yartemlea Faces Headwinds While We Wait On Pipeline Developments
TipRanks·2d ago
Omeros Announces Major Convertible Notes Repurchase Plan
Benzinga·06/29 12:11
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
NASDAQ·06/26 19:27
Noteworthy Friday Option Activity: OMER, QCOM, REPL
Reuters·06/26 17:50
BUZZ-U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
Benzinga·06/26 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
Reuters·06/26 16:43
BUZZ-U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
Dow Jones·06/26 15:39
Omeros Price Target Cut to $33.00/Share From $40.00 by HC Wainwright & Co.
Dow Jones·06/26 15:39
Omeros Is Maintained at Buy by HC Wainwright & Co.
TipRanks·06/26 15:30
Omeros price target lowered to $33 from $40 at H.C. Wainwright
Benzinga·06/26 15:28
HC Wainwright & Co. Maintains Buy on Omeros, Lowers Price Target to $33
Seeking Alpha·06/26 15:22
Acadia rises as EU backs Rett syndrome therapy
Benzinga·06/26 15:16
FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide
Same Industry
Name/Symbol
Change%
Price